News
Drug marketing practices come under scrutiny
BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7456.10-a (Published 01 July 2004) Cite this as: BMJ 2004;329:10- Fred Charatan
- Florida
Federal prosecutors have issued subpoenas to several drug makers, including Johnson and Johnson, Wyeth, and Bristol-Myers Squibb, as part of an investigation from Boston, Massachusetts, into a pattern of financial incentives that the major drug makers have used to persuade doctors to favour their drugs.
The action comes after a number of doctors revealed the ploys allegedly adopted by the various …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £157 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.